Tenon Medical Inc (TNON)
0.9199
-0.06
(-6.11%)
USD |
NASDAQ |
May 15, 14:26
Tenon Medical Enterprise Value: 2.397M for May 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 2.397M |
| May 13, 2024 | 2.019M |
| May 10, 2024 | 2.058M |
| May 09, 2024 | 1.876M |
| May 08, 2024 | 1.950M |
| May 07, 2024 | 1.913M |
| May 06, 2024 | 1.879M |
| May 03, 2024 | 1.913M |
| May 02, 2024 | 1.764M |
| May 01, 2024 | 1.650M |
| April 30, 2024 | 1.559M |
| April 29, 2024 | 1.492M |
| April 26, 2024 | 1.546M |
| April 25, 2024 | 1.466M |
| April 24, 2024 | 1.595M |
| April 23, 2024 | 1.392M |
| April 22, 2024 | 1.503M |
| April 19, 2024 | 1.477M |
| April 18, 2024 | 1.540M |
| April 17, 2024 | 1.615M |
| April 16, 2024 | 1.686M |
| April 15, 2024 | 1.451M |
| April 12, 2024 | 1.730M |
| April 11, 2024 | 1.991M |
| April 10, 2024 | 2.073M |
| Date | Value |
|---|---|
| April 09, 2024 | 2.101M |
| April 08, 2024 | 1.972M |
| April 05, 2024 | 2.211M |
| April 04, 2024 | 2.141M |
| April 03, 2024 | 2.286M |
| April 02, 2024 | 2.293M |
| April 01, 2024 | 2.211M |
| March 28, 2024 | 1.215M |
| March 27, 2024 | 1.086M |
| March 26, 2024 | 1.228M |
| March 25, 2024 | 1.306M |
| March 22, 2024 | 1.423M |
| March 21, 2024 | 1.475M |
| March 20, 2024 | 1.423M |
| March 19, 2024 | 1.345M |
| March 18, 2024 | 1.553M |
| March 15, 2024 | 1.709M |
| March 14, 2024 | 1.709M |
| March 13, 2024 | 1.657M |
| March 12, 2024 | 2.515M |
| March 11, 2024 | 2.463M |
| March 08, 2024 | 2.203M |
| March 07, 2024 | 2.151M |
| March 06, 2024 | 1.891M |
| March 05, 2024 | 1.995M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.093M
Minimum
Sep 11 2023
568.71M
Maximum
May 09 2022
16.07M
Average
5.053M
Median
Enterprise Value Benchmarks
| QuidelOrtho Corp | 5.282B |
| Perspective Therapeutics Inc | 1.025B |
| Xtant Medical Holdings Inc | 122.50M |
| Asensus Surgical Inc | 54.79M |
| Catheter Precision Inc | 3.117M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.134M |
| Revenue (Quarterly) | 0.808M |
| Total Expenses (Quarterly) | 3.949M |
| EPS Diluted (Quarterly) | -1.205 |
| Gross Profit Margin (Quarterly) | 69.18% |
| Profit Margin (Quarterly) | -387.9% |
| Earnings Yield | -1.12K% |
| Normalized Earnings Yield | -1127.80 |